Pyrazinamide is an antimycobacterial medication within the pyrazinecarboxamide class that is primarily used in combination with rifamycins to treat tuberculosis by inhibiting the growth of Mycobacterium… Read more







Pyrazinamide is an antimycobacterial medication within the pyrazinecarboxamide class that is primarily used in combination with rifamycins to treat tuberculosis by inhibiting the growth of Mycobacterium tuberculosis. Laboratories require accurate characterization of this pharmaceutical during research and development, necessitating high-quality reference standards for the active pharmaceutical ingredient. This category includes pharmacopeial and non-pharmacopeial impurities, such as pyrazinoic acid and 2-cyanopyrazine, which are essential for conducting impurity profiling and establishing analytical methods. Additionally, stable isotope-labeled compounds, such as deuterated and 15N-labeled pyrazinamide derivatives, are available to serve as internal standards in mass spectrometry. These materials are critical for verifying method accuracy, supporting stability studies, and ensuring rigorous quality control throughout the pharmaceutical manufacturing and testing lifecycle.